Cells are processed at 1~5M per second and soon to be >50M cells per second.
Each 5 x 10 mm device can process >50M cells with a >1B cell device in development.
µVS is optimised to yield the maximum amount of recovered, viable and modified cells.
µVS processing results in minimal perturbation of the T cell state for high quality cells.
The µVS Delivery System™ is currently available for Research Use Only. A clinical system is in development and will be regulated as a tool for biologics manufacturing. Both systems are developed in an ISO 13485-compliant manner and all materials in the flow path are medical-grade or USP Class VI implantable-grade. µVS devices for high-throughput screening of small volumes based on the well plate format are also in development.